(Q42249714)

19 October 2017

Hepatitis C virus dysregulates glucose homeostasis by a dual mechanism involving induction of PGC1α and dephosphorylation of FoxO1. (English)

1 reference

19 October 2017

1 reference

3

1 reference

19 October 2017

D Calabrese

2

0 references

author name string

C Bernsmeier

series ordinal

1

1 reference

PubMed ID

24329853

19 October 2017

H T F Duong

series ordinal

4

1 reference

19 October 2017

6 November 2013

1 reference

Journal of Viral Hepatitis

19 October 2017

1 reference

19 October 2017

21

1 reference

19 October 2017

1

1 reference

19 October 2017

9-18

1 reference

Physiologic action of glucagon on liver glucose metabolism

19 October 2017

1 reference

Novel concepts in insulin regulation of hepatic gluconeogenesis

21 January 2018

1 reference

Positive and negative regulation of insulin signaling through IRS-1 phosphorylation

21 January 2018

1 reference

Phosphorylation of glycosyl-phosphatidylinositol by phosphatidylinositol 3-kinase changes its properties as a substrate for phospholipases.

21 January 2018

1 reference

IRS-1 activates phosphatidylinositol 3'-kinase by associating with src homology 2 domains of p85

21 January 2018

1 reference

mTORC2 protein complex-mediated Akt (Protein Kinase B) Serine 473 Phosphorylation is not required for Akt1 activity in human platelets [corrected].

21 January 2018

1 reference

Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor

21 January 2018

1 reference

PGC-1alpha: a key regulator of energy metabolism

21 January 2018

1 reference

Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction

21 January 2018

1 reference

Insulin regulates liver metabolism in vivo in the absence of hepatic Akt and Foxo1

21 January 2018

1 reference

Hepatitis C virus core protein upregulates serine phosphorylation of insulin receptor substrate-1 and impairs the downstream akt/protein kinase B signaling pathway for insulin resistance

21 January 2018

1 reference

Hepatitis C virus activates the mTOR/S6K1 signaling pathway in inhibiting IRS-1 function for insulin resistance

21 January 2018

1 reference

Virus-induced over-expression of protein phosphatase 2A inhibits insulin signalling in chronic hepatitis C.

21 January 2018

1 reference

The formation and activity of PP2A holoenzymes do not depend on the isoform of the catalytic subunit

21 January 2018

1 reference

Autoregulation of protein phosphatase type 2A expression

21 January 2018

1 reference

Functional interaction between a novel protein phosphatase 2A regulatory subunit, PR59, and the retinoblastoma-related p107 protein

21 January 2018

1 reference

Inhibition of Alpha Interferon Signaling by Hepatitis B Virus

21 January 2018

1 reference

Activation of endoplasmic reticulum stress response by hepatitis viruses up-regulates protein phosphatase 2A.

21 January 2018

1 reference

Methylated C-terminal leucine residue of PP2A catalytic subunit is important for binding of regulatory Balpha subunit

21 January 2018

1 reference

PP2A regulates the pro-apoptotic activity of FOXO1.

21 January 2018

1 reference

Hepatitis C virus inhibits interferon signaling through up-regulation of protein phosphatase 2A.

21 January 2018

1 reference

Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras

21 January 2018

1 reference

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

Increased pancreatic beta-cell proliferation mediated by CREB binding protein gene activation

21 January 2018

1 reference

The forkhead transcription factor FoxO1 regulates proliferation and transdifferentiation of hepatic stellate cells

21 January 2018

1 reference

Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance

21 January 2018

1 reference

The metabolic regulator PGC-1α links hepatitis C virus infection to hepatic insulin resistance.

21 January 2018

1 reference

Fostriecin, an antitumor antibiotic with inhibitory activity against serine/threonine protein phosphatases types 1 (PP1) and 2A (PP2A), is highly selective for PP2A.

21 January 2018

1 reference

Hepatitis C virus genotype 3 is cytopathic to hepatocytes: Reversal of hepatic steatosis after sustained therapeutic response

21 January 2018

1 reference

Impact of HCV genetic differences on pathobiology of disease.

21 January 2018

1 reference

Cellular serine/threonine phosphatase activity during human cytomegalovirus infection

21 January 2018

1 reference

Viral infections as potential triggers of type 1 diabetes

21 January 2018

1 reference

Association of type 2 diabetes mellitus and seroprevalence for cytomegalovirus

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/JVH.12208

1 reference

19 October 2017

1 reference

PubMed ID

24329853